BRPI0409032A - método para a produção de micropartìculas à base de emulsão - Google Patents
método para a produção de micropartìculas à base de emulsãoInfo
- Publication number
- BRPI0409032A BRPI0409032A BRPI0409032-2A BRPI0409032A BRPI0409032A BR PI0409032 A BRPI0409032 A BR PI0409032A BR PI0409032 A BRPI0409032 A BR PI0409032A BR PI0409032 A BRPI0409032 A BR PI0409032A
- Authority
- BR
- Brazil
- Prior art keywords
- emulsion
- production
- based microparticles
- vessel
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
- B01F25/452—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces
- B01F25/4524—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through foam-like inserts or through a bed of loose bodies, e.g. balls
- B01F25/45241—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through foam-like inserts or through a bed of loose bodies, e.g. balls through a bed of balls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
- B01J2/06—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/14—Powdering or granulating by precipitation from solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Polymers & Plastics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
Abstract
"MéTODOS E APARELHO PARA PREPARAçãO E PRODUçãO DE MICROPARTìCULAS à BASE DE EMULSãO". Para a produção de micropartículas á base de emulsão que contêm um agente biológico ou químico, sendo que o aparelho compreende um vaso; material de compactação situado dentro de tal vaso, e também pode compreender um material que pode ser inserido em ambas as extremidades do dito vaso para encerrar o material de compactação; em uma realização particular, o aparelho é de leito compactado; os métodos incluem a produção de micropartículas à base de emulsão que contêm um agente biológico ou químico; a utilidade da presente invenção é que os aparelhos e os métodos da presente invenção propiciam uma produção não turbulenta de baixo cisalhamento de micropartículas à base de emulsão que resulta em uma distribuição de tamanho de partícula estreita reproduzível, que pode ser utilizada com volumes grandes e pequenos que podem ser convenientemente escalonados para cima enquanto propiciam propriedades de emulsão previsíveis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46186003P | 2003-04-10 | 2003-04-10 | |
PCT/US2004/011485 WO2005003180A2 (en) | 2003-04-10 | 2004-04-12 | A method for the production of emulsion-based micro particles |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0409032A true BRPI0409032A (pt) | 2006-05-02 |
Family
ID=33563700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0409032-2A BRPI0409032A (pt) | 2003-04-10 | 2004-04-12 | método para a produção de micropartìculas à base de emulsão |
Country Status (10)
Country | Link |
---|---|
US (2) | US8916196B2 (pt) |
EP (2) | EP2548550A1 (pt) |
JP (3) | JP2007515392A (pt) |
CN (2) | CN101410174B (pt) |
AU (1) | AU2004253853B2 (pt) |
BR (1) | BRPI0409032A (pt) |
CA (1) | CA2516107C (pt) |
ES (1) | ES2427092T3 (pt) |
PT (1) | PT1615959E (pt) |
WO (1) | WO2005003180A2 (pt) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070207211A1 (en) * | 2003-04-10 | 2007-09-06 | Pr Pharmaceuticals, Inc. | Emulsion-based microparticles and methods for the production thereof |
AU2004253853B2 (en) * | 2003-04-10 | 2010-04-01 | Evonik Corporation | A method for the production of emulsion-based micro particles |
AU2004259208B2 (en) | 2003-07-15 | 2011-04-28 | Evonik Corporation | Method for the preparation of controlled release formulations |
EP2444069B1 (en) * | 2003-07-23 | 2019-06-05 | Evonik Corporation | Controlled release compositions |
DE102006013531A1 (de) * | 2006-03-24 | 2007-09-27 | Lts Lohmann Therapie-Systeme Ag | Polylactid-Nanopartikel |
US10092524B2 (en) | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
US8951567B2 (en) | 2007-09-27 | 2015-02-10 | Akina, Inc. | Sol-gel phase-reversible hydrogel templates and uses thereof |
EP2219620B1 (en) * | 2007-11-13 | 2017-07-19 | Surmodics, Inc. | Viscous terpolymers as drug delivery platform |
EP2259677A4 (en) | 2008-02-29 | 2011-11-02 | Alseres Pharmaceuticals Inc | SYSTEMIC PURINARY ADMINISTRATION FOR MODULATING THE AXONAL GROWTH OF THE CENTRAL NERVOUS SYSTEM |
US8951546B2 (en) * | 2008-12-23 | 2015-02-10 | Surmodics Pharmaceuticals, Inc. | Flexible implantable composites and implants comprising same |
US8974808B2 (en) * | 2008-12-23 | 2015-03-10 | Surmodics, Inc. | Elastic implantable composites and implants comprising same |
US9415197B2 (en) * | 2008-12-23 | 2016-08-16 | Surmodics, Inc. | Implantable suction cup composites and implants comprising same |
US20100168807A1 (en) * | 2008-12-23 | 2010-07-01 | Burton Kevin W | Bioactive terpolymer compositions and methods of making and using same |
US9480643B2 (en) * | 2008-12-23 | 2016-11-01 | Surmodics Pharmaceuticals, Inc. | Implantable composites and implants comprising same |
WO2010075298A2 (en) | 2008-12-23 | 2010-07-01 | Surmodics Pharmaceuticals, Inc. | Implantable composites and compositions comprising releasable bioactive agents |
EP2389161A2 (en) * | 2009-01-23 | 2011-11-30 | Surmodics Pharmaceuticals, Inc. | Controlled release systems from polymer blends |
WO2010085608A1 (en) | 2009-01-23 | 2010-07-29 | Surmodics Pharmaceuticals, Inc. | Polymer mixtures comprising polymers having different non-repeating units and methods for making and using same |
JP2012515790A (ja) * | 2009-01-23 | 2012-07-12 | サーモディクス ファーマシューティカルズ, インコーポレイテッド | 微粒子製造のための連続二重エマルジョン工程 |
JP5791629B2 (ja) * | 2009-12-22 | 2015-10-07 | エボニック コーポレイションEvonik Corporation | 微粒子を調製する乳剤基調プロセス、及び、プロセスで利用されるワークヘッド構造体 |
CN103124592B (zh) * | 2010-07-01 | 2015-05-27 | 科瓦里斯股份有限公司 | 使用聚焦声制备用于纳米递送之纳米制剂和系统的组合物和方法 |
EP2611868B1 (en) | 2010-08-30 | 2020-01-08 | Surmodics Pharmaceuticals, Inc. | Biodegradable terpolymers and terpolymer blends as pressure-sensitive adhesives |
CN104772056A (zh) * | 2010-12-23 | 2015-07-15 | 赢创有限公司 | 用来制备乳化液的设备和方法 |
SG193991A1 (en) | 2011-04-05 | 2013-11-29 | Edge Therapeutics | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
US9399019B2 (en) | 2012-05-09 | 2016-07-26 | Evonik Corporation | Polymorph compositions, methods of making, and uses thereof |
WO2014074114A1 (en) | 2012-11-09 | 2014-05-15 | Evonik Corporation | Drying methods for tuning microparticle properties |
US9439864B2 (en) | 2014-07-07 | 2016-09-13 | Antriabio, Inc. | Solvent extraction from biodegradable microparticles |
JP5801974B1 (ja) * | 2015-02-12 | 2015-10-28 | 株式会社Nextコロイド分散凝集技術研究所 | 多層エマルションの製造方法、及びカプセルの製造方法 |
CN109069416A (zh) | 2016-02-23 | 2018-12-21 | 拜欧帝力威瑞科学有限公司 | 缓释丁丙诺啡微球(srbm)及其使用方法 |
CA3022693A1 (en) * | 2016-05-16 | 2017-11-23 | Amag Pharmaceuticals, Inc. | Polymeric extended release compositions of hydroxyprogesterone caproate and methods of using same |
GB201615066D0 (en) * | 2016-09-06 | 2016-10-19 | Ge Healthcare Bioprocess R&D Ab | Packed bed emulsification |
GB2555658A (en) * | 2016-11-01 | 2018-05-09 | Cambridge Consultants | Microparticle production |
GB201622024D0 (en) * | 2016-11-14 | 2017-02-08 | Inventage Lab Inc | Apparatus and method for large scale production of monodisperse, microsheric and biodegradable polymer-based drug delivery |
JP7218344B2 (ja) * | 2017-07-10 | 2023-02-06 | 武田薬品工業株式会社 | 液体をインキュベートおよびウイルスを不活化するための方法 |
CN111051381A (zh) * | 2017-09-03 | 2020-04-21 | 赢创运营有限公司 | 用于增材制造的生物相容聚合物粉末 |
WO2019104225A1 (en) | 2017-11-22 | 2019-05-31 | Dauntless 2, Inc. | Therapeutic compound formulations |
DE102019104646A1 (de) * | 2018-02-26 | 2019-08-29 | Adelheid Holzmann | Verfahren zum Betreiben einer Verbrennungskraftmaschine, eine Anordnung zur Durchführung des Verfahrens zum Betreiben einer Verbrennungskraftmaschine und eine Vorrichtung zur Erzeugung einer Emulsion |
WO2020236950A1 (en) | 2019-05-21 | 2020-11-26 | Dauntless 1, Inc. | Therapeutic microsphere formulations containing charged polymers |
WO2020236957A1 (en) | 2019-05-21 | 2020-11-26 | Dauntless 1, Inc. | Therapeutic microsphere formulations containing end-capped polymers |
WO2021083989A1 (en) | 2019-10-31 | 2021-05-06 | Evonik Operations Gmbh | Process for preparing nano- or microparticles comprising a carrier-polymer and one or more biologically active ingredients |
WO2022183196A1 (en) | 2021-02-24 | 2022-09-01 | Oakwood Laboratories, Llc | Microsphere formulations comprising lurasidone and methods for making and using the same |
WO2024074585A2 (en) | 2022-10-05 | 2024-04-11 | Mireca Medicines Gmbh | MICROPARTICLE AND IMPLANT FORMULATIONS FOR cGMP ANALOG THERAPY |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3664963A (en) * | 1969-10-22 | 1972-05-23 | Balchem Corp | Encapsulation process |
US3780195A (en) * | 1969-10-22 | 1973-12-18 | Balchem Corp | Encapsulation process |
DE2059494B2 (de) * | 1970-12-03 | 1972-03-16 | Licentia Gmbh | Biegsamer hohlleiter |
JPS523342B2 (pt) * | 1972-01-26 | 1977-01-27 | ||
US3865352A (en) * | 1973-11-16 | 1975-02-11 | Minnesota Mining & Mfg | Static mixing device |
DE2604832A1 (de) * | 1976-02-07 | 1977-08-11 | Basf Ag | Verfahren zur analyse von loesungen |
US4171981A (en) * | 1977-04-29 | 1979-10-23 | The Mead Corporation | Process for the production of hot melt coating compositions containing microcapsules |
US4183681A (en) | 1978-05-19 | 1980-01-15 | Exxon Research & Engineering Co. | Emulsion preparation method using a packed tube emulsifier |
US4299501A (en) * | 1979-08-10 | 1981-11-10 | Ortho Pharmaceutical Corporation | Continuous process for the preparation of semisolid dispersions |
US4933105A (en) * | 1980-06-13 | 1990-06-12 | Sandoz Pharm. Corp. | Process for preparation of microspheres |
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
US4501501A (en) * | 1983-03-04 | 1985-02-26 | E. I. Du Pont De Nemours And Company | Process for dispersing solids in liquid media |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
DE3732370A1 (de) | 1987-09-25 | 1989-04-06 | Hoechst Ag | Verfahren zur vermischung von lebenden zellen oder mikroorganismen mit einer viskosen fluessigkeit und mischungen, die nach diesem verfahren hergestellt wurden |
CA2050911C (en) * | 1989-05-04 | 1997-07-15 | Thomas R. Tice | Encapsulation process and products therefrom |
PH30995A (en) * | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
US5538739A (en) * | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
US5112604A (en) * | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
MY107937A (en) * | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
FR2660556B1 (fr) | 1990-04-06 | 1994-09-16 | Rhone Poulenc Sante | Microspheres, leur procede de preparation et leur utilisation. |
US6120805A (en) * | 1990-04-06 | 2000-09-19 | Rhone-Poulenc Rorer Sa | Microspheres, process for their preparation and their use |
US5733566A (en) * | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
NZ260909A (en) * | 1993-07-05 | 1995-04-27 | Takeda Chemical Industries Ltd | Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution |
WO1995013799A1 (en) * | 1993-11-19 | 1995-05-26 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable microparticles containing a biologically active agent |
GB9412273D0 (en) * | 1994-06-18 | 1994-08-10 | Univ Nottingham | Administration means |
WO1997004747A1 (en) | 1995-07-27 | 1997-02-13 | Dunn James M | Drug delivery systems for macromolecular drugs |
US5629277A (en) * | 1995-10-04 | 1997-05-13 | William L. Brown | Paint removing composition |
US6140040A (en) * | 1995-10-06 | 2000-10-31 | Advanced Minerals Corporation | Method of mechanically separating microparticles suspended in fluids using particulate media |
EP0799616A1 (en) * | 1996-04-01 | 1997-10-08 | Takeda Chemical Industries, Ltd. | Oral composition comprising a fumagillol derivative |
US5792477A (en) * | 1996-05-07 | 1998-08-11 | Alkermes Controlled Therapeutics, Inc. Ii | Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent |
JPH10109024A (ja) | 1996-10-04 | 1998-04-28 | Jasco Corp | エマルション調整方法及び装置 |
AU5678398A (en) | 1997-01-29 | 1998-08-18 | Takeda Chemical Industries Ltd. | Sustained-release microspheres, their production and use |
JPH10273447A (ja) | 1997-01-29 | 1998-10-13 | Takeda Chem Ind Ltd | 徐放性マイクロスフィア、その製造法および用途 |
SE9701161D0 (sv) | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use I |
MY118835A (en) * | 1997-04-18 | 2005-01-31 | Ipsen Pharma Biotech | Sustained release compositions and the process for their preparation |
CA2314934C (en) * | 1997-12-16 | 2006-08-29 | Chiron Corporation | Use of microparticles combined with submicron oil-in-water emulsions |
EP1048301A4 (en) * | 1998-01-16 | 2005-03-09 | Takeda Chemical Industries Ltd | COMPOSITIONS WITH DELAYED ACTIVE INGREDIENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE |
JPH11349688A (ja) | 1998-06-05 | 1999-12-21 | Reika Kogyo Kk | 徐放性複合エマルション、徐放性微粒子及びその製造方法 |
US6270700B1 (en) * | 1998-07-23 | 2001-08-07 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Encapsulation of water soluble peptides |
JP3012608B1 (ja) | 1998-09-17 | 2000-02-28 | 農林水産省食品総合研究所長 | マイクロチャネル装置及び同装置を用いたエマルションの製造方法 |
US6194006B1 (en) * | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
EP1044683A1 (en) | 1999-04-15 | 2000-10-18 | Debio Recherche Pharmaceutique S.A. | One-step dispersion method for the microencapsulation of water soluble substances |
US6291013B1 (en) * | 1999-05-03 | 2001-09-18 | Southern Biosystems, Inc. | Emulsion-based processes for making microparticles |
US7919119B2 (en) * | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
EP1222213A1 (en) * | 1999-10-08 | 2002-07-17 | The Procter & Gamble Company | APPARATUS AND PROCESS FOR IN-LINE PREPARATION OF HIPEs |
JP3303856B2 (ja) | 1999-10-12 | 2002-07-22 | 松下電器産業株式会社 | 液晶表示パネルと製造方法 |
US6495166B1 (en) | 1999-11-12 | 2002-12-17 | Alkermes Controlled Therapeutics Inc. | Apparatus and method for preparing microparticles using in-line solvent extraction |
AUPQ529000A0 (en) * | 2000-01-28 | 2000-02-17 | Research Laboratories Of Australia Pty Ltd | Toner characterization cell |
US6953593B2 (en) * | 2000-02-01 | 2005-10-11 | Lipoprotein Technologies, Inc. | Sustained-release microencapsulated delivery system |
US6264987B1 (en) * | 2000-05-19 | 2001-07-24 | Alkermes Controlled Therapeutics Inc. Ii | Method for preparing microparticles having a selected polymer molecular weight |
US6306423B1 (en) * | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
US6565873B1 (en) | 2000-10-25 | 2003-05-20 | Salvona Llc | Biodegradable bioadhesive controlled release system of nano-particles for oral care products |
EP2316490A3 (en) | 2000-10-31 | 2012-02-01 | PR Pharmaceuticals, Inc. | Methods and compositions for enhanced delivery of bioactive molecules |
EP1352269A2 (en) | 2001-01-15 | 2003-10-15 | 3M Innovative Properties Company | Multilayer infrared reflecting film with high and smooth transmission in visible wavelength region and laminate articles made therefrom |
WO2002058672A2 (en) | 2001-01-26 | 2002-08-01 | Debio Recherche Pharmaceutique S.A. | Microparticles of biodegradable polymer encapsulating a biologically active substance |
TWI332407B (en) * | 2001-06-29 | 2010-11-01 | Takeda Chemical Industries Ltd | Controlled release composition and method of producting the same |
DE60311801T2 (de) | 2002-05-02 | 2007-11-08 | PR Pharmaceuticals, Inc., Fort Collins | Zusammensetzungen aus östradiol-metaboliten mit kontrollierter freisetzung |
EP1829529A1 (en) * | 2002-05-03 | 2007-09-05 | PR Pharmaceuticals, Inc. | Controlled release compositions of estradiol metabolites |
EP1605894A2 (en) | 2003-03-05 | 2005-12-21 | PR Pharmaceuticals | Oxytocin controlled release formulations and methods of using same |
US20070207211A1 (en) * | 2003-04-10 | 2007-09-06 | Pr Pharmaceuticals, Inc. | Emulsion-based microparticles and methods for the production thereof |
AU2004253853B2 (en) | 2003-04-10 | 2010-04-01 | Evonik Corporation | A method for the production of emulsion-based micro particles |
US9040664B2 (en) | 2003-04-11 | 2015-05-26 | Antriabio, Inc. | Materials and methods for preparing protein-polymer conjugates |
AU2004259208B2 (en) * | 2003-07-15 | 2011-04-28 | Evonik Corporation | Method for the preparation of controlled release formulations |
EP2444069B1 (en) | 2003-07-23 | 2019-06-05 | Evonik Corporation | Controlled release compositions |
-
2004
- 2004-04-12 AU AU2004253853A patent/AU2004253853B2/en not_active Expired
- 2004-04-12 EP EP12159499A patent/EP2548550A1/en not_active Withdrawn
- 2004-04-12 BR BRPI0409032-2A patent/BRPI0409032A/pt active Search and Examination
- 2004-04-12 WO PCT/US2004/011485 patent/WO2005003180A2/en active Application Filing
- 2004-04-12 ES ES04750117T patent/ES2427092T3/es not_active Expired - Lifetime
- 2004-04-12 EP EP04750117.6A patent/EP1615959B1/en not_active Expired - Lifetime
- 2004-04-12 CA CA2516107A patent/CA2516107C/en not_active Expired - Lifetime
- 2004-04-12 CN CN2004800084088A patent/CN101410174B/zh not_active Expired - Lifetime
- 2004-04-12 JP JP2006532408A patent/JP2007515392A/ja active Pending
- 2004-04-12 US US10/553,003 patent/US8916196B2/en active Active
- 2004-04-12 PT PT47501176T patent/PT1615959E/pt unknown
- 2004-04-12 CN CN201110028030XA patent/CN102166192B/zh not_active Expired - Lifetime
-
2009
- 2009-12-25 JP JP2009296315A patent/JP5377277B2/ja not_active Expired - Lifetime
-
2013
- 2013-01-28 JP JP2013013176A patent/JP2013136591A/ja active Pending
-
2014
- 2014-11-14 US US14/541,328 patent/US10272044B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2005003180A2 (en) | 2005-01-13 |
JP5377277B2 (ja) | 2013-12-25 |
US20150072928A1 (en) | 2015-03-12 |
US10272044B2 (en) | 2019-04-30 |
EP1615959B1 (en) | 2013-06-05 |
CN101410174B (zh) | 2011-04-06 |
CN102166192B (zh) | 2013-09-25 |
US8916196B2 (en) | 2014-12-23 |
JP2013136591A (ja) | 2013-07-11 |
ES2427092T3 (es) | 2013-10-28 |
JP2007515392A (ja) | 2007-06-14 |
CN102166192A (zh) | 2011-08-31 |
PT1615959E (pt) | 2013-08-29 |
AU2004253853B2 (en) | 2010-04-01 |
CN101410174A (zh) | 2009-04-15 |
CA2516107A1 (en) | 2005-01-13 |
AU2004253853A1 (en) | 2005-01-13 |
WO2005003180A3 (en) | 2009-04-02 |
EP2548550A1 (en) | 2013-01-23 |
EP1615959A4 (en) | 2009-11-25 |
EP1615959A2 (en) | 2006-01-18 |
US20070190154A1 (en) | 2007-08-16 |
CA2516107C (en) | 2013-12-24 |
JP2010120948A (ja) | 2010-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0409032A (pt) | método para a produção de micropartìculas à base de emulsão | |
Jha et al. | Two-dimensional finite element model to study calcium distribution in astrocytes in presence of excess buffer | |
Hayat et al. | Mixed convective peristaltic flow of Carreau–Yasuda fluid with thermal deposition and chemical reaction | |
JP2021500092A5 (pt) | ||
Das et al. | Effect of magnetic field on Oldroyd-B type nanofluid flow over a permeable stretching surface | |
DE602004014156D1 (de) | Rotierende rührvorrichtung mit enger verteilung des energieumwandlungsgrads und verfahren | |
Khan et al. | Comparative analysis for radiative slip flow of magnetized viscous fluid with mixed convection features: Atangana-Baleanu and Caputo-Fabrizio fractional simulations | |
Beckert et al. | A model of interfacial permeability for soft seals in marine-organism, suction-based adhesion | |
Cao et al. | A study of fractional Oldroyd-B fluid between two coaxial cylinders containing gold nanoparticles | |
Akinbo et al. | Radiation and thermal-diffusion interaction on stagnation-point flow of Walters' B fluid toward a vertical stretching sheet | |
TW200712013A (en) | The method and apparatus for treatment of wastewater containing insoluble substances | |
Rahawy | Treatment of anestrous in buffalo cows by massaging the uterus and ovaries rectally. | |
CN203736235U (zh) | 一种斑贴试验粘稠试剂加样器 | |
Kee et al. | Development of a gel formulation with human umbilical cord mesenchymal stem cell-derived exosomes (UC-MSC-Exo) for cosmetic applications. | |
Pratiwi et al. | Surface Morphology Analysis of Nanohydroxyapatyte Using Electrochemical Method for Biomedical Engineering. | |
Querleu et al. | Randomized study of aggressive surgery for advanced ovarian cancer | |
Jeerachaipansakul et al. | The influence of demineralization process on physicochemical characteristics, BMP-2 quantification of human demineralized tooth matrix. | |
Gujrathi et al. | FORMULATION AND EVALUATION OF FLOATING BIOADHESIVE TABLET OF GLIPIZIDE. | |
Tao et al. | Innentitelbild: Antimonene Quantum Dots: Synthesis and Application as Near-Infrared Photothermal Agents for Effective Cancer Therapy (Angew. Chem. 39/2017). | |
IV et al. | THE PROSPECTS TO OBTAINING STEM CELLS FROM ADIPOSE TISSUE BY TECHNOLOGY OF TRACK MEMBRANES. | |
Xin et al. | Development of Comprehensive Experimental Teaching and Laboratory Construction for Biomedical Engineering Specialty | |
Bertsch et al. | Adsorption, Structure, and Rheology of Cellulose Nanocrystals at the Air-Water Interface | |
Jeong et al. | Polymer Bulletin: Synthesis and Characterization of Polymeric Foaming Agent Containing Sulfonyl Hydrazide Moiety | |
Shukova Stojmanovska et al. | Differences in body composition between 12 years old pupils both genders from center and suburb | |
Rahemi et al. | Stochastic modeling of knee arthrometry for Intact, partial and ruptured ACL |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25C | Requirement related to requested transfer of rights |
Owner name: PR PHARMACEUTICALS (US) , EHUD ZEIGERSON (US) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B25B | Requested transfer of rights rejected |
Owner name: PR PHARMACEUTICALS (US) , EHUD ZEIGERSON (US) |
|
B15G | Petition not considered as such [chapter 15.7 patent gazette] | ||
B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: PR PHARMACEUTICALS (US) , EHUD ZEIGERSON (US) |
|
B25E | Requested change of name of applicant rejected |
Owner name: PR PHARMACEUTICALS (US) , EHUD ZEIGERSON (US) |
|
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 16A ANUIDADE |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.6 NA RPI NO 2580 DE 16/06/2020. |